Used in the minimally invasive treatment of pathologies of the thoracic aorta, the ZENITH ALPHA thoracic stent is indicated for the treatment of patients with lesions isolated from the descending aortathoracic (excluding dissections), whose vascular anatomical configuration is suitable for endovascular repair, including: anatomical iliac / femorala adequate for access with the required introduction systems non-aneurysmal aortic segments (fixation sites) proximal and distal with respect to the thoracic lesion: with a minimum length of 20mm, and with a mean external wall diameter exterior wall not exceeding 42mm and not less than 15mm.
Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.